Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FAT1 upregulation is correlated with an immunosuppressive tumor microenvironment and predicts unfavorable outcome of immune checkpoint therapy in non-small cell lung cancer. | Heliyon | 2024 | 38560204 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients with EGFR-mutated non-small cell lung cancer treated with afatinib. | ERJ Open Res | 2024 | 38500795 | PubTator, text mining | PubMed |
| [Expression of FAT1 in Lung Adenocarcinoma and Its Relationship with Immune Cell Infiltration]. | Zhongguo Fei Ai Za Zhi | 2024 | 38453442 | PubTator, text mining | PubMed |
| External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control? | Head Neck | 2024 | 38445804 | PubTator, text mining | PubMed |
| Mutation detection in saliva from oral cancer patients. | Oral Oncol | 2024 | 38412584 | PubTator, text mining | PubMed |
| Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid. | Curr Issues Mol Biol | 2024 | 38392182 | PubTator, text mining | PubMed |
| Acquired cystic disease-associated renal cell carcinoma with PTCH1 mutation: a case report. | Front Oncol | 2024 | 38371617 | PubTator, text mining | PubMed |
| Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets. | Mod Pathol | 2024 | 38369186 | PubTator, text mining | PubMed |
| Clinical value of FAT1 mutations to indicate the immune response in colorectal cancer patients. | Genomics | 2024 | 38364976 | PubTator, text mining | PubMed |
| Machine Learning-Based Classification of Transcriptome Signatures of Non-Ulcerative Bladder Pain Syndrome. | Int J Mol Sci | 2024 | 38338847 | PubTator, text mining | PubMed |
| Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights. | PNAS Nexus | 2024 | 38328782 | PubTator, text mining | PubMed |
| Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma. | Sci Rep | 2024 | 38287071 | PubTator, text mining | PubMed |
| The Role of CD4/6 Inhibitors in Breast Cancer Treatment. | Int J Mol Sci | 2024 | 38279242 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | 38275409 | PubTator, text mining | PubMed |
| Seize the engine: Emerging cell cycle targets in breast cancer. | Clin Transl Med | 2024 | 38264947 | PubTator, text mining | PubMed |
| The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway. | Mol Cancer | 2024 | 38263180 | PubTator, text mining | PubMed |
| Assessing White Matter Engagement in Brain Networks through Functional and Structural Connectivity Mapping. | bioRxiv | 2024 | 38260265 | PubTator, text mining | PubMed |
| Activated Human Adipose Tissue Transplantation Promotes Sensorimotor Recovery after Acute Spinal Cord Contusion in Rats. | Cells | 2024 | 38247873 | PubTator, text mining | PubMed |
| Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma. | EBioMedicine | 2024 | 38244291 | PubTator, text mining | PubMed |
| Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations. | Respir Res | 2024 | 38238740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=19